Additional 5 Years of AI Treatment Reduces Distant Recurrence Rates Among Postmenopausal Women Already Treated with at Least 5 Years of Endocrine Therapy By Ogkologos - August 25, 2025 624 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a meta-analysis performed by the Early Breast Cancer Trialists’ Collaborative Group Source RELATED ARTICLESMORE FROM AUTHOR ESMO Announces 2026 Society Award Recipients Honouring Excellence in Cancer Research, Care and Leadership Adjuvant Olaparib Continues to Improve Multiple Outcomes in Patients with Germline BRCA1/2-associated High-Risk HER2-negative EBC EMA Recommends Refusing the Marketing Authorisation for Copper (64Cu) Oxodotreotide MOST POPULAR Food for Thought: A Fresh Perspective on Nutrition February 5, 2021 ¿Las gammagrafías óseas muestran el cáncer? April 28, 2021 ¿El azúcar provoca cáncer? September 20, 2022 ScottishPower help us shine a light on air pollution and cancer December 9, 2021 Load more HOT NEWS 2023 Highlights in Treating Genitourinary Cancers: Expert Perspectives Can Topical Drugs Help Prevent Breast Cancer? Switching to Camizestrant While Continuing a CDK4/6 Inhibitor After ESR1 Mutation... Glucose Control Key in Reducing Cancer Risk for People with Type...
